Akhilesh Pandey, M.D., Ph.D. obtained his M.D. from Armed Forces Medical College, Pune and completed his residency in Pathology at the Brigham and Women's Hospital, Harvard Medical School.
He earned his Ph.D. in the laboratory of Vishva Dixit at the University of Michigan, Ann Arbor in 1995 and carried out his postdoctoral work in the laboratory of Harvey Lodish at the Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology from 1996-1999.
Dr. Pandey was a visiting scientist with Matthias Mann at the University of Southern Denmark from 1999-2002 before joining Johns Hopkins in 2002. He is is currently a Professor at the Institute of Genetic Medicine and at the Departments of Biological Chemistry and Oncology and Pathology at the Johns Hopkins University School of Medicine.
Dr. Pandey has been an editorial board member of Genome Research and BMC Bioinformatics and currently serves as an editorial board member of Molecular and Cellular Proteomics, Journal of Proteome Research, Proteomics, Clinical Proteomics, Journal of Translational Medicine and DNA Research and as an associate editor of Journal of Proteomics. He is also the founder and director of the Institute of Bioinformatics, a non-profit research institute in Bangalore, India.
Dr. Pandey developed the SILAC method in Matthias Mann's laboratory and continues to apply this technique in many areas including signaling and biomarker discovery. Dr. Pandey's laboratory is known for taking a systems biology approach by combining many "Omics" technologies, and his laboratory has recently completed a draft map of the human proteome.
He has received numerous prestigious awards including the Experimental Pathologist-In-Training Award by the American Society for Investigative Pathology, the Howard Temin Award from the National Cancer Institute, the Sidney Kimmel Scholar Award by the Sidney Kimmel Foundation for Cancer Research and the Beckman Young Investigator Award by Arnold and Mabel Beckman Foundation.
He has recently received the Era of Hope Scholar Award by the Department of Defense which is "intended for exceptionally talented, early-career scientists who have demonstrated that they are the best and the brightest in their field(s) through extraordinary creativity, vision, and productivity, and who have shown a strong potential for leadership in the breast cancer community as well as a vision for the eradication of breast cancer."
Dr. Pandey’s research focuses on an interdisciplinary approach using molecular biology, mass spectrometry and computational biology to identify proteins; characterize post-translational modifications in signal transduction pathways; identify potential biomarkers and identify therapeutic targets in cancer.